I-Strattera kunye no-Adderall bobabini imishanguzo echanekileyo yokunceda ukuphatha i- ADHD . Bathuthukisa ingqalelo kwithuba kunye nokunciphisa uxinzelelo kunye nokunyanzelisa. Nangona kunjalo, ahlukeneyo amayeza. Uluhluko obalaseleyo phakathi kwezi zimbini kukuba i-Strattera ayiyona into ekhuthazayo, ngelixa i-Adderall yimiyeza evuselela ingqondo (evuselelayo).
Strattera
I-Strattera ligama legama lesigqirha esine-atomoxetine.
Yavunywe yi-Food and Drug Administration (FDA) ngo-2002, kwaye yaba yipilisi yokuqala engakhuseliyo yokufumana imvume kwi-ADHD. Kwakhona kwakuye imichiza yokuqala yokuvunyelwa ukuphathwa ngabantu abadala nge-ADHD . Inokumiselwa abantu abaneminyaka engama-6 ubudala nangaphezulu.
I-Strattera yi-norepinephrine reuptake inhibitor (NRI), oku kuthetha ukuba ivumela i-neurotransmitter i-norepinephrin ukuba ifumaneke kwi-neurons yengqondo ixesha elide. Kwakhona kuphakamisa ubuninzi be-dopamine kwi-correction ye-cortex yengqondo.
Adderall
I-Adderall ligama legama lesigqirha esenziwe nge dextroamphetamine kunye ne-amphetamine. Yingxowankulu ye-amphetamine. I-FDA ivume le ngonyango ngo-1996. Ukongezelela kwi-ADHD, iphinda ivunyiwe ukuphatha i-narcolepsy. Inokumiselwa kubantu abaneminyaka eli-6 ubudala nangaphezulu.
I-Adderall yenza kwi-system central nerveous by enhancing the quantity of neurotransmitters engqondweni.
Ukwanda kwe-dopamine kunye ne-norepinephrine kusiza umntu ekukwazi ukugxila kunye nokunyamekela, ngelixa kunciphisa ukunyanzeliswa nokuziphatha okungathandekiyo.
Izigaba ezimbini zeMithi ye-ADHD
I-ADHD amayeza ahlulwe ngamacandelo amabini; Umgca wokuqala wemithi kunye nemigca yesibini yomgca.
Iyeza ezinomtsalane ezinjenge-Adderall ziyaziwa ngokuba yinkqubo efanelekileyo yonyango ye-ADHD, ngoko ke ithathwa njengamachiza okuqala kumgca.
Amachiza angakhuseliyo njengamaStrattera amachiza emibini emibini. Ngelixa bengabasebenzi ngendlela ekhuthazayo, basaya kunceda iimpawu ze- ADHD. Ngokomzekelo, uphando lubone ukuba i-Strattera yanciphisa iimpawu ezingabonakaliyo kubantu abadala xa kuthelekiswa ne-placebo Nangona kunjalo, iipesenti ezingama-40 zabathathi-nxaxheba zichaze iimpawu ezibalulekileyo ze-ADHD.
Nangona izikhuthazo ziyeza kakhulu, azisebenzi kuwo wonke umntu. Ukongezelela, ngamanye amaxesha umntu ufumana iimiphumo ezibi kakhulu, okanye unempilo yonyango ephakamileyo eyandisa ubungozi bokuthabatha njengembali yobunzima, imeko yesifo sengqondo njengengxaki yokuguquguquka kwengqondo, okanye imeko yesimo senhliziyo okanye ukugula kwesifo.
Kule meko, amayeza angakhuseliyo njengeStrattera iyona khetho. I-Strattera iye yafunyanwa ngamanye amaxesha kunceda ngeemeko ezihlala zikhona kunye ne-ADHD njengexhala kunye nokuchasana nokuziphatha okungcolileyo.
Ngaba i-Strattera ikhuselekile kuneAdderall?
I-Adderall yinto elawulwayo yeShedyuli II. Oku kuthetha ukuba kunokusetyenziswa kakubi, kunye nokusetyenziswa okude kunokubangela ukuxhomekeka. Ngenxa yokuba i-Adderall yendlela yokwenza ukunyusa umsebenzi we- dopamine engqondweni, ingasetyenziswa kakubi kwaye ifakwe nge-inhaled okanye injected ukudala phezulu.
Kuyathakazelisa ukuba uphando lubonise ukuba xa umntu ethatha isigulana sokunyanga kwemithi banesilinganiso esincinane sokusetyenziswa kakubi ngokweziyobisi xa kuthelekiswa nomntu ongathathi lolu hlobo lweyeza. Oku kubangelwa ukuba xa i-ADHD iphathwa ngokukhuselekileyo, abantu abanako amathuba okuzimela kunye nokusebenzisa iindlela ezingagunyazisiyo zokulawula i-ADHD yabo.
Xa unyango olungummiselo lunqunywe kwii-doses ezifanelekileyo, kwaye ukuba kuthathwe njengoko kuchaziwe, umngcipheko wokulutha umlingo uphantsi. Gcina rhoqo amayeza akho ngokuphepha kwabanye abantu, kwaye musa ukwabelana ngamachiza akho.
Njengemithi engavuselelanga, iStrattera ayikho into elawulwayo kwaye ayinayo ingozi yokusetyenziswa kakubi.
Isebenza ngokuvimbela i-norepinephrin, kodwa kunokuthi ichaphazele i-dopamine. Ngenxa yokuba ithatha iiveki eziliqela ukuba iyeza kusebenza, kuya kuba nzima ukusetyenziswa kakubi.
Olunye ukhuseleko oluqhelekileyo abantu banalo malunga nokuthatha imithi ekhuthazayo njenge-Adderall yinto echaphazelekayo enokuthi ibe nayo entliziyweni. Uphando lufumene ukuba ubunzima beengxaki zentliziyo kunye nokusetyenziswa kwemichiza ekhuthazayo kakhulu kunabantu abaphilileyo. Ngokomzekelo, uphando oluthile lufumene ukuba abantu kwiimpawu ezikhuthazayo ze-ADHD abazange banomngcipheko wokwenyuka kweemeko zengqondo ezifana nokuhlaselwa kwintliziyo, ukubetha, okanye ukufa komzimba.
Kwixesha elidlulileyo, izigulane zine-electrocardiography (EKG) yokuhlola ukuba ngaba kuya kunikwa imithi ekhuthazayo. Ngokufumana uphando olutsha, oku kuhlolwayo akusisidingo ngaphandle kokuba wena, okanye umntu onentsapho yakho, eneengxaki zeengqondo. Ukuba uthabatha kwaye uqaphele nayiphi na imiqondiso engavamile, qha ga mshelana nodokotela wakho.
IiFom kunye neMilinganiselo
I-Strattera ifumaneka kwi-capsule yomlomo efika kwiiyure eziyisixhenxe ukusuka kwi-10 ukuya kwi-100 milligram (mg).
Ayikho inguqu ye-Strattera efumaneka kwi-US okwangoku, nangona oko kungatshintshwa ngokukhawuleza njengoko i-patent iphelile ngo-2017. Kukho ii-generic zeStrattera ezifumaneka eCanada nakwamanye amazwe.
I-Adderall IR (ukukhutshwa ngokukhawuleza) ifumaneka kumacwecwe avela ku-5 mg ukuya ku-30 mg. I-Adderall XR (ukukhululwa okwandisiweyo) ifumaneka kumanqanaba ayisithandathu, ukusuka kwi-5 mg ukuya kwi-30 mg. Kukho imishanguzo ekhoyo (i-amphetamine ityuwa inhlanganisela). Ngamanye amaxesha abantu bakuchaza oku asebenzelanga kubo njengenguqu yegama.
Imiphumela
Kuzo zombini iyeza, oogqirha badla i-dose ephantsi ukuqala kunye nokunyuka kwangoko kuze kube yilapho i-dose yokwelapha efanele ifunyenwe wena kunye neempawu zakho. Oku kuthetha ukuba uya kuba nemiphumo emibini njengoko umzimba wakho ulungelelanisa kumachiza.
Imiphumo emibi yeStrattera ifaka umlomo owomileyo, utywala, isisu esicasulayo kunye nokunciphisa ukutya, ukunqandwa, ukunciphisa i-libido, nokukhupha. Amadoda anokufumana usebenziso oluthile lwe-erectile.
Imiphumo emibi ye-Adderall ibandakanya ukulahleka kwesidlo, isifo sohudo, isisu, umlomo owomileyo, umkhuhlane, intloko, ukungazinzi, isisulu, isisulu, ukuphazamiseka, ukuhlanza nokulahleka kwesisindo, kunye ne-erectile dysfunction . Eyona nto ingathintekiyo, kodwa imiphumo engabonakaliyo emibi yandisa izinga lentliziyo, ingcinezelo yegazi ephezulu, i-hallucinations, paranoia, ukuphefumula okufutshane, ukuhlaselwa yintliziyo, kunye nesifo.
Isilumkiso seBlack Black
I-FDA ibonisa isilumkiso sebhokisi emnyama kwezinye iileyibrari zamachiza ezonyango ukwenzela ukuba ingqalelo ingozi ebalulekileyo okanye yobungozi obufunekayo isigulane.
I-Strattera inesixwayiso sebhokisi elimnyama ukwenzela ukuba inokwenzeka ingozi yokuzibulala okanye isenzo sabantwana, intsha kunye nabantu abadala. Abazali nabanakekeli bayakhuthazwa ukuba bajonge utshintsho olwenzekayo kwindlela yokuziphatha komntwana, ngaphezu kokugcina ubudlelwane obusondeleyo nodokotela wengane.
I-Adderall ineexwayiso ezimbini zeebhokisi ezimnyama. Okokuqala kukugqamisa ukusetyenziswa kokusetyenziswa kakubi. Okwesibini ukuxwayisa malunga neemeko zentliziyo.
Kwa bafazi
Zomibini imichiza yinkqubo yeC C, kwaye ithathwa njengingaphephekanga ukuthatha ngexesha lokukhulelwa okanye ngexesha lokuncelisa. Thetha ugqirha wakho ukuba ukhulelwe okanye uceba ukukhulelwa.
Iimithi Zithatha Kude Kangakanani?
Ingathatha iiveki ezine ukuya ezintandathu ngaphambi kokuba iStrattera ifinyelele kwisiphumo sayo sonyango. Xa amazinga okunyanga afikelelwe, imiphumo yonyango idlulileyo iiyure ezingama-24. Ngokwahlukileyo, imiphumo ye-Adderall IR ne-Adderall XR inokuvakalelwa ngokukhawuleza njengemizuzu engama-30 kwiyure enye. Imiphumo ye-Adderall IR iqalisa ukuguquka emva kweeyure ezine, kwaye emva kweeyure eziyi-12 ze-Adderall XR.
Ieholide zeziyobisi zikhethwa ukuba wena, okanye umntwana wakho, uthathe i-Adderall. Emva kokuxoxa ngale ngxelo nogqirha wakho, awukwazi ukuthatha iAdderall ngeveki okanye ngaphezulu kweeholide. I-Strattera kufuneka ithathwe rhoqo imihla.
ILizwi
Bobabini i-Adderall kunye ne-Strattera ziyimpatho ye-ADHD. Nangona kunjalo, ngelixa i-Strattera inceda abantu abathile abahlala ne-ADHD, ukuphumelela kwayo akukwenzeka ngokufanayo rhoqo njengoko kuya kwenzeka ngeyeza ezinomtsalane ezifana ne-Adderall. Yingakho kuyindlela yokwenza unyango lwesibini.
Ukuba uqwalasela i-Adderall okanye i-Strattera njengenxalenye yonyango lwe-ADHD kuwe okanye umntwana wakho, xubusha nodokotela wakho okanye udokotela wezilwanyana. Ugqirha uya kuba nako ukunceda ukuba wenze isigqibo sokuba ngaba unyango luyinto efanelekileyo kuwe.
> Imithombo:
Adler, L., Y Tanaka, D Williams, PT Trzepacz, T. Goto, AJ Allen, R. Escobar, kunye noH. P Upadhyaya. 2014. Umsebenzi oLawulayo kwiiNkcukacha eziPhezulu ngeeNkcazo-Ukusilela / Ukuxhatshazwa kwengxaki ngexesha lotyando kunye ne-Atomoxetine kwiSifundo esiLawulayo sokuLawula i-Placebo-Controls . Umbhalo we-Clinical psychopharmacology 34 (4): 461-466.
UBederman, J., MC Monuteaux, T. Spencer. TE Wilens, H. A Macpherson, kunye noSV Faraone. Ngo-2008. Utyholongwane olushukumisayo kunye neengozi yokusetyenziswa kwezidakamizwa zokusetyenziswa kwezidalwa kubantu abadala abesilisa abane-ADHD: Ulawulo lweNdalo yokuFunda. I-American Journal ye-Psychiatry 165 (5)): 597 -603.
Cooper, WO, L,. A. Habel, CM Sox, KA Chan, PG Arbogast, kunye neTC Cheerham. Ngo-2011 I-New England Journal of Medicine 365: 1896-1904
UMolina, BSG, SP Hinshaw, LEA Arnold, J. M Swanson, WE Pelham, uL. Hechtman et al, 2013. Ukusetyenziswa kwezinto ezisebuntwaneni kwi-Multimodal Treatment Study Yokunqongophala kweNkcazo / Ukuxhatshazwa kwengqondo (ADHD) (iMTA) njengeSebenza I-ADHD yabantwana, isabelo esingenangqungquthela kwiZonyango zabantwana, kunye neMithi. I-American Academy Yomntwana kunye ne-Adolescent Psychiatry 52 (3): 250-263.
Schwarz, S., kunye noCU Correll, ngo-2014. Ukusebenza kunye noKhuseleko lwe-Atomoxetine kwi-Children and Adolescents Ukunyamekela-Ukungaphumeleli / ukuxhatshazwa kwengqondo: Iziphumo ezivela kwi-Meta-Analysis Comprehensive and Analysis. Umbhalo we-American Academy of Child and Adolescent Psychiatry. 55 (2): 174-187